Biovest International Inc.(fka BVTIQ)

[deadjim]

I haven't kept track of this one in awhile.. there was an NDA coming at some point if not already filed. Either way, I see some bearish articles and potential catalysts at some point in the future (good for me). Is ABPI still considered the way to go over BVTI, since ABPI owns the majority of BVTI?
I remember BVTI having a wider trading range and being the strongest of the two when both moved

[rickochey]

http://ih.advfn.com/p.php?pid=nmona&article=48180007&symbol=ABPI

[PETERDENIEL2003]

Biovest Meets Skeptic's Requirements for 'The Next Dendreon' - Part 4


http://seekingalpha.com/user/182011/comments/symbol/bvti.pk

[casperboo]

I'm expecting the FDA to give BiovaxID conditional approval sooner than anyone expects - and I mean in Q4 2011. The share price will jump 20-30X minimum when they do.

Are others loading up at .50? I don't expect BVTI to slide any lower.

[rickochey]

Its just a manner of time... Although the FDA doesn;t normally approve these kinds of drugs it still can be a good cash machine in the near future.

[casperboo]

I added more myself this week. I expect a partnership or an outright buyout within 4 months. And when the new facility becomes operational, look out above. Buying this stock under .65 is a steal...

GLTA.

[Gogo1121]

I freaking love this stock at these prices!! I really think there is tremendous upside for folks that have a 12 month time frame!!

[Gogo1121]

I own 3 times as many shares at .74! 100k shares I may add if things get lower than .55 Hang on for the upside ahead!

[casperboo]

Holding 27,000 shares here at an average .84 and feeling real good about it.

BLA spells GAINS.

NEW FACILITY spells GAINS.

NEW HIRES means SUCCESS which also spells GAINS.

FDA APPROVAL spells GAINS.

GAINS, GAINS, GAINS.

It's all just a matter of time, and imho, .62 won't last.

Get in now!

GLTA.

[gracie0717]

anyone try to trade today?

[schlitz]

in for 3k this morning. eom

[rickochey]

Nice another positive even. I am excited about the share price as it gives me time to load up.

[rickochey]

It is funny you posted this. I was just on the BVTI website and was thinking the same thing. All we are waiting on is the FDA approval. Yes this company has recently had a rocky past but I feel this company is so far under radar.

[casperboo]

How can a company that is building a new drug manufacturing facility and is about to submit a BLA for a multi-billion dollar drug be trading under 1.00 when it was trading above 2.00 months ago but with fewer positive developments then than now?

24,000 shares here and thinking seriously about getting more...The fire sale CAN'T and SHOULDN'T last.

[casperboo]

I added more today at .68.

[Gogo1121]

I couldn't agree more that that statement! BVTI is going nowhere but higher. I'm a buyer of this stock below .70 a share. GLTA

[casperboo]

stockta.com is very reliable and is showing substantial resistance between .84 and .94. Sellers there will someday soon be sorry...

GLTA.

[casperboo]

I was not happy to see .75 print today. May the 2.00 prophecy be our gap up pps in the near future...

16,000 shares here...

GLTA.

[Gogo1121]

The management on this company is astonished by the current valuation. In their interpretation of the recent news shares of BVTI should be trading north of $2 a shares. The damage associated with the sale of shares by creditors wasn't anticipated but, as most biotech companies know they have little to do with the streets interpretation of value. As news unfolds over the next few months shares should respond positively.

[rickochey]

Will anyone be watching this? If yo are can I get an honest report from you?

[Gogo1121]

Doctors have known for some time that people’s immune systems may help fight their cancer. In rare instances, these people’s immune systems have rejected their cancers, and they have been cured. Scientists are now trying to develop ways to encourage this immune reaction by the use of vaccines.

Unlike vaccines against infections like measles or mumps, these vaccines are designed to help treat, not prevent, lymphomas. The goal is to create an immune reaction against lymphoma cells in patients who have very early disease or in patients whose disease is in remission. One possible advantage of these types of treatments is that they seem to have very limited side effects. So far, there have been a few successes with this approach, and it is a major area of research in lymphoma treatment. At this time lymphoma vaccines are only available in clinical trials.

BiovaxID™ is a vaccine based on the unique genetic makeup of a patient’s B-cell non-Hodgkin lymphoma. The vaccine uses a unique protein (part of an antibody called an idiotype) taken from each patient’s own lymphoma cells, which are obtained during a biopsy. This is combined with substances that boost the body’s immune response when the combination is injected into the patient. A late-stage clinical trial found that in people with follicular lymphomas that went away after chemotherapy, the vaccine lengthened the time before the lymphoma came back by more than a year. The vaccine is not yet available outside of clinical trials.

[bottomed_out]

Someone just posted on another board that the short interest is very low and he believes that even shortie has BVTI undervalued. Can this be confirmed? If shortie does think BVTI is undervalued, will this lead the way to less resistance if the price starts to appreciate?

[Gogo1121]

I rest my case! There is news this morning that further clarify s the Phase III trail results! This stock close the year above $1. YOW!!

[Gogo1121]

Creditors are done selling shares of BVTI !
Share climb back above $1 before year end. Short squeeze helps push the shares back to $1.40 in January 2011.

[joe_techi]

$0.88 on comparatively low volume. Seems the creditors will sell no matter the price.

[rickochey]

Does anyone remember or have the dates for the fast track?

[Gogo1121]

Damn the bleeding here just wont stop!! Sam Duffey and friends should have been more protective of the creditors dumping shares of BVTI on the heels of such great news!! I bought more today at $1 and will set a few limit orders at .90 and .80 just in case. This stock runs back above $2 a share once the creditors are done selling their shares!!

[Atlanta1]

no telling how low it could go, but it bounced nicely yesterday from this level.

I've added at $1.09

[rickochey]

How much lower can this go?

Anyone have any info when the FDA has the fast track date?

[Atlanta1]

This all sure looks favorable to me. I have established a position and look forward to further positive developments.

[Gogo1121]

Biovest’s President, Mr. Samuel S. Duffey, stated, “It is our sincere hope that this new data and its impact on future cancer vaccine development will be important to patients suffering from lymphoma. There is no other cancer vaccine that we are aware of, either approved or in clinical trials, that has conducted an isotype/idiotype analysis such as that reported today for BiovaxID. We believe that this new data may have potentially paradigm-changing implications to the future of cancer vaccine development and accordingly, we have filed new patent applications in order to add another layer of protection for BiovaxID, as well as potentially covering other new vaccines and products that may be developed based on this technology.”

[Gogo1121]

http://finance.yahoo.com/news/Biovest-Reports-a-Significant-bw-2714053276.html?x=0&.v=1

[rickochey]

http://seekingalpha.com/article/239948-biovest-poised-to-boost-shareholder-value-with-cancer-vaccine

[Gogo1121]

http://ash.confex.com/ash/2010/webprogram/Paper34600.html

[Gogo1121]

Creditors have been selling shares since Biovest announced that they would be resolving their Bankruptcy issues. This recent pull back is a buying opportunity. Aren't they presenting at a conference next week in Orlando Fl? I believe that I read somewhere that BVTI is presenting Monday at a Hematology conference next week. I agree with your comment about shares of BVTI climbing back to $2 very quickly....GLTA

[rickochey]

The only thing That I can come up with is it came out of bK and is an OTC. BUT I still don't understand how this company can have the fast track withe the FDA and still not much interest. Monday will be very telling.


i claim to have no knowledge of trading...

[bottomed_out]

I've been keeping an eye on BVTI for a couple of months now. Personally, I think this is a good buying opportunity. What I don't understand is why the stock took such a hit when they emerged from bankruptcy. Was there some stock dilution going on? What's to stop BVTI from climbing back to $2.00+?

[rickochey]

Why not is this company and product under the radar> I have no idea!
It has the fast track with the FDA and orphan drug status..

http://ash.confex.com/ash/2010/webprogram/Paper34600.html

[rickochey]

such a great potential with this company and product. Great article in teh previous thread.

[Getac1ue2]

more good news...........
http://www.themarketfinancial.com/biovest-international-otcbvtithe-next-potential-winner-in-cancer-immunotherapy-vaccine-after-dendreon-nasdaqdndn/108696

[rickochey]

I just bought 100 shares of this company.

[rickochey]

I just bought 100 shares of this company.

[rickochey]

Is anyone else interested in this stock along with ABPIQ? something has been erking me about this company's cancer stuff. that these two companies will be big time.

[$pmlg]

[HDOGTX]

BVTI 8k out, looks like good things coming!

[Getac1ue2]

Ballots posted for voting.

http://www.srbp.com/accentia/accentia.htm

return required by Sept 17th, Confirmation hearing Sept 22nd 1:00pm EST

[Getac1ue2]

Biovest Bioreactor System

http://finance.yahoo.com/news/Naval-Health-Research-Center-bw-69990411.html?x=0&.v=1

the good news just keeps coming

[Getac1ue2]

09/22/2010 next court date
@04:00PM 08-17795-8M1 ACCENTIA BIOPHARMACEUTICALS, INC., ET AL
Atty:CHARLES A. POSTLER
Trustee:UNITED STATES TRUSTEE - TPA, 1

1 - CONFIRMATION

2 - FOURTH APPLICATION FOR COMPENSATION FOR SALAWANCHICK, LLOYD AND SALAWANCHICK, SPECIAL COUNSEL, DOC. #840, FOR THE PERIOD 6/1/10 THROUGH 7/31/10 ($14,117.41/$10,973.13)

pulled from netdoc's

[Getac1ue2]

TAMPA, Fla. & MINNEAPOLIS, Aug 05, 2010 (BUSINESS WIRE) -- Biovest
International, Inc. (OTCQB: "BVTI"), a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company has retained the investment banking firm, ROTH Capital Partners, LLC (ROTH). ROTH has been engaged to assist Biovest in raising capital
as the Company prepares to emerge from Chapter 11 reorganization.

[deadjim]

I could never get a read on where ABPIQ and BVTI should be trading if/when fda actually accepts their NDA. I don't have my charts on this laptop but seems one of them had atleast a 3-4 dollar range. ABPIQ I think? I find it interesting the stock prices are now closing in to each other.. which is telling me something about ABPIQ yes? I'm gonna go out on a leash and say ABPIQ will be the drug of choice for the momentum players when the time comes.